Sildenafil for selective serotonin reuptake inhibitor-induced erectile dysfunction in elderly male depressed patients

J Sex Marital Ther. 2003 Jul-Aug;29(4):297-303. doi: 10.1080/00926230390195533.

Abstract

Treatment with antidepressants, especially agents with potent serotonergic effects, is frequently associated with sexual side effects. In the present study, we examined the efficacy of sildenafil, a potent phosphodiesterase inhibitor, in the treatment of elderly men (n = 10; 70-81 years) with erectile dysfunction induced by antidepressant treatment for major depressive disorder. Eligible subjects were instructed to add sildenafil (25-50 mg/day) to their current drug treatment. Clinical assessment of erectile function was performed at beginning of treatment with sildenafil and at follow up, 4 weeks later. All patients reported an improvement of their erectile capacity, and in 7 out of 10 subjects, erectile function returned to a normal level. Sildenafil appears to be a safe and well-tolerated agent in elderly subjects. We noted side effects in 2 patients (flashes), but the side-effects were bothersome only to one patient (headache). It appears that sildenafil coadministration improves erectile dysfunction associated with selective serotonin reuptake inhibitor ongoing treatment in elderly patients.

MeSH terms

  • Aged
  • Depressive Disorder / drug therapy
  • Dose-Response Relationship, Drug
  • Ejaculation / drug effects*
  • Erectile Dysfunction / chemically induced*
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / psychology
  • Humans
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Phosphodiesterase Inhibitors / administration & dosage*
  • Piperazines / administration & dosage*
  • Purines
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Severity of Illness Index
  • Sildenafil Citrate
  • Sulfones
  • Time Factors
  • Treatment Outcome
  • Vasodilator Agents / administration & dosage*

Substances

  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Serotonin Uptake Inhibitors
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate